SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-19-026368
Filing Date
2019-12-17
Accepted
2019-12-18 08:33:49
Documents
5

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d1219adams_advansource.htm SC 13D 69078
2 ASSET PURCHASE AGREEMENT, DATED NOVEMBER 25, 2019, BY AND BETWEEN ADVANSOURCE BI sc13d1219ex10-1_advan.htm EX-10.1 751612
3 FORMOF VOTING AND SUPPORT AGREEMENT sc13d1219ex10-2_advan.htm EX-10.2 79386
4 GRAPHIC exb_001.jpg GRAPHIC 16338
5 GRAPHIC exb_002.jpg GRAPHIC 12339
  Complete submission text file 0001213900-19-026368.txt   941218
Mailing Address 229 ANDOVER STREET WILMINGTON MA 01887
Business Address 229 ANDOVER STREET WILMINGTON MA 01887 978-657-0075
AdvanSource Biomaterials Corp (Subject) CIK: 0001011060 (see all company filings)

IRS No.: 043186647 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-48655 | Film No.: 191291370
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 78 E OLYMPIA AVE C/O CARDIO TECH INTERNATIONAL INC WOBURN MA 01810-2057
Business Address
ADAMS MICHAEL F (Filed by) CIK: 0001253828 (see all company filings)

Type: SC 13D